DIMENSIONAL FUND ADVISORS LP

Position in DTIL — Precision Biosciences Inc

CIK 354204 AUSTIN, TX

Position in DTIL

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$679,582

+$580,754 QoQ

Shares Held

86,461

+263.9% QoQ

Ownership

0.313%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#27

of 95 holders

Holding Since

Dec 2021

13 quarters on record

Voting authority Sole 79% Shared 17% None 4%

Healthcare · as of Jun 30, 2026

DIMENSIONAL FUND ADVISORS LP holds $6,105,781,867 across 230 Biotechnology names. DTIL ranks #171 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,168,956	$580,655,511
2	JAZZ	Jazz Pharmaceuticals plc	1,713,592	$412,924,262
3	REGN	Regeneron Pharmaceuticals, Inc.	559,687	$348,987,230
4	INCY	Incyte Corp	2,280,803	$258,551,825
5	EXEL	Exelixis, Inc.	4,426,620	$240,852,392
6	BMRN	Biomarin Pharmaceutical Inc	4,075,714	$233,212,353
7	ROIV	Roivant Sciences Ltd.	5,230,417	$185,104,455
8	KRYS	Krystal Biotech, Inc.	476,038	$176,929,041

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$679,582	86,461	+263.9%	Shares	Sole	2026-08-11
2025-12-31	$98,828	23,757	-45.6%	Shares	Sole	2026-02-12
2025-09-30	$240,898	43,641	-18.6%	Shares	Sole	2025-11-12
2025-06-30	$225,250	53,631	0.0%	Shares	Sole	2025-08-12
2025-03-31	$255,819	53,631	-3.3%	Shares	Sole	2025-05-13
2024-12-31	$211,359	55,475	-41.9%	Shares	Sole	2025-02-13
2023-06-30	$50,212	95,463	-0.2%	Shares	Sole	2023-08-09
2023-03-31	$72,146	95,687	0.0%	Shares	Sole	2023-05-12
2022-12-31	$113,866	95,687	0.0%	Shares	Sole	2023-02-09
2022-09-30	$124,392	95,687	-45.7%	Shares	Sole	2022-11-10
2022-06-30	$282,027	176,268	-36.7%	Shares	Sole	2022-08-12
2022-03-31	$858,346	278,684	-4.8%	Shares	Defined	2022-05-13
2021-12-31	$2,165,358	292,616	—	Shares	Defined	2022-02-09
No filing history on record for this holder in this stock.